Skip to content
10-K

Annual Report

Juno Therapeutics, Inc.

0001594864-18-000005

← back to feed
Filed
Mar 1, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Feb 21, 2018 116.11M sh
Stock Repurchased FY 2017 · Dec 31, 2017 $0
Stock Repurchased FY 2017 · Dec 31, 2016 $10.07M
Stock Repurchased FY 2017 · Dec 31, 2015 $0
Capex FY 2017 · Dec 31, 2017 $60.92M
Capex FY 2017 · Dec 31, 2016 $56.25M
Capex FY 2017 · Dec 31, 2015 $28.18M
Operating Cash Flow FY 2017 · Dec 31, 2017 −$225.03M
Operating Cash Flow FY 2017 · Dec 31, 2016 −$189.81M
Operating Cash Flow FY 2017 · Dec 31, 2015 $7.33M
Long Term Debt FY 2017 · Dec 31, 2017 $9.95M
Long Term Debt FY 2017 · Dec 31, 2016 $0
Cash And Equivalents FY 2017 · Dec 31, 2017 $232.78M
Cash And Equivalents FY 2017 · Dec 31, 2016 $187.89M
Cash And Equivalents FY 2017 · Dec 31, 2015 $252.4M
Cash And Equivalents FY 2017 · Dec 31, 2014 $355.97M
Stockholders Equity FY 2017 · Dec 31, 2017 $1.05B
Stockholders Equity FY 2017 · Dec 31, 2016 $1.08B
Stockholders Equity FY 2017 · Dec 31, 2015 $1.14B
Stockholders Equity FY 2017 · Dec 31, 2014 $388.53M
Current Liabilities FY 2017 · Dec 31, 2017 $208.75M
Current Liabilities FY 2017 · Dec 31, 2016 $114.89M
Current Assets FY 2017 · Dec 31, 2017 $753.35M
Current Assets FY 2017 · Dec 31, 2016 $772.33M
Total Assets FY 2017 · Dec 31, 2017 $1.43B
Total Assets FY 2017 · Dec 31, 2016 $1.35B
Sga Expense FY 2017 · Dec 31, 2017 $108.13M
Sga Expense FY 2017 · Dec 31, 2016 $70.68M
Sga Expense restated FY 2017 · Dec 31, 2015 $57.16M
Rd Expense FY 2017 · Dec 31, 2017 $451.52M
Rd Expense FY 2017 · Dec 31, 2016 $264.29M
Rd Expense FY 2017 · Dec 31, 2015 $205.16M
Net Income FY 2017 · Dec 31, 2017 −$136.04M
Net Income FY 2017 · Dec 31, 2017 −$437.11M
Net Income FY 2017 · Sep 30, 2017 −$118.13M
Net Income FY 2017 · Jun 30, 2017 −$100.74M
Net Income FY 2017 · Mar 31, 2017 −$82.2M
Net Income FY 2017 · Dec 31, 2016 −$52.78M
Net Income FY 2017 · Dec 31, 2016 −$245.58M
Net Income FY 2017 · Sep 30, 2016 −$56.9M
Net Income FY 2017 · Jun 30, 2016 −$64.77M
Net Income FY 2017 · Mar 31, 2016 −$71.14M
Net Income FY 2017 · Dec 31, 2015 −$239.38M
Operating Income FY 2017 · Dec 31, 2017 −$138.21M
Operating Income FY 2017 · Dec 31, 2017 −$447.77M
Operating Income FY 2017 · Sep 30, 2017 −$121.8M
Operating Income FY 2017 · Jun 30, 2017 −$103.44M
Operating Income FY 2017 · Mar 31, 2017 −$84.32M
Operating Income FY 2017 · Dec 31, 2016 −$55.71M
Operating Income FY 2017 · Dec 31, 2016 −$255.6M
Operating Income FY 2017 · Sep 30, 2016 −$58.47M
Operating Income FY 2017 · Jun 30, 2016 −$61.52M
Operating Income FY 2017 · Mar 31, 2016 −$79.9M
Operating Income FY 2017 · Dec 31, 2015 −$244.1M
Revenue FY 2017 · Dec 31, 2017 $26.46M
Revenue FY 2017 · Dec 31, 2017 $111.87M
Revenue FY 2017 · Sep 30, 2017 $44.82M
Revenue FY 2017 · Jun 30, 2017 $21.27M
Revenue FY 2017 · Mar 31, 2017 $19.33M
Revenue FY 2017 · Dec 31, 2016 $21.15M
Revenue FY 2017 · Dec 31, 2016 $79.36M
Revenue FY 2017 · Sep 30, 2016 $20.83M
Revenue FY 2017 · Jun 30, 2016 $27.6M
Revenue FY 2017 · Mar 31, 2016 $9.78M
Revenue FY 2017 · Dec 31, 2015 $18.22M